Open AccessPresentation and treatment of aggressive, Triple‐Negative carcinosarcoma of the breast
Author(s) -
Vizgan Niels,
Jokar Tahereh Orouji,
Enayati Ladan,
Salyana Muhammad,
Gotlieb Vladimir K.
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.6020
Subject(s) - carcinosarcoma , medicine , breast cancer , triple negative breast cancer , presentation (obstetrics) , oncology , stage (stratigraphy) , cancer , pathology , surgery , carcinoma , biology , paleontology
An extremely rare form of breast cancer, breast carcinosarcoma accounts for less than a percent of all breast malignancies and is highly aggressive. Composed of both cancerous epithelial and mesenchymal cell types, breast carcinosarcoma is associated with a poor prognosis compared to more common breast cancers, and typically lack the receptors typical of other breast carcinomas, which minimize potential targets for treatment. In this case report, we discuss a 56‐year‐old patient affected by carcinosarcoma of the breast at a T2N1 stage, and the decision‐making process that factored into her treatment plan.